Alexandra Berk

839 total citations
20 papers, 585 citations indexed

About

Alexandra Berk is a scholar working on Oncology, Economics and Econometrics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Alexandra Berk has authored 20 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Economics and Econometrics and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Alexandra Berk's work include Health Systems, Economic Evaluations, Quality of Life (4 papers), Economic and Financial Impacts of Cancer (3 papers) and Cancer survivorship and care (3 papers). Alexandra Berk is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (4 papers), Economic and Financial Impacts of Cancer (3 papers) and Cancer survivorship and care (3 papers). Alexandra Berk collaborates with scholars based in United States. Alexandra Berk's co-authors include Yuelin Li, David M. Panicek, Hedvig Hricak, Lawrence H. Schwartz, Doris F. Chang, Christina Cho, Jimmie C. Holland, Christian J. Nelson, Andrew Roth and Xianchen Liu and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and Radiology.

In The Last Decade

Alexandra Berk

19 papers receiving 568 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexandra Berk United States 7 303 110 105 74 68 20 585
Linda Bresolin United States 11 229 0.8× 60 0.5× 36 0.3× 37 0.5× 49 0.7× 19 426
Ciaran Grafton‐Clarke United Kingdom 13 113 0.4× 100 0.9× 39 0.4× 29 0.4× 43 0.6× 51 646
Shivani Reddy United States 13 148 0.5× 283 2.6× 178 1.7× 88 1.2× 33 0.5× 26 865
Anthony Flynn United States 10 88 0.3× 345 3.1× 32 0.3× 36 0.5× 53 0.8× 33 733
Gregory Patton United States 6 114 0.4× 39 0.4× 43 0.4× 33 0.4× 20 0.3× 12 339
Heidi Probst United Kingdom 12 201 0.7× 47 0.4× 41 0.4× 36 0.5× 17 0.3× 42 412
Hyo‐Chun Yoon United States 9 135 0.4× 102 0.9× 34 0.3× 29 0.4× 21 0.3× 17 369
Sharon Schiro United States 12 134 0.4× 25 0.2× 21 0.2× 44 0.6× 41 0.6× 32 538
Benard Ohene Botwe Ghana 14 308 1.0× 35 0.3× 58 0.6× 19 0.3× 98 1.4× 72 562
Jason A. Freed United States 11 33 0.1× 98 0.9× 57 0.5× 27 0.4× 7 0.1× 39 446

Countries citing papers authored by Alexandra Berk

Since Specialization
Citations

This map shows the geographic impact of Alexandra Berk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandra Berk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandra Berk more than expected).

Fields of papers citing papers by Alexandra Berk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandra Berk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandra Berk. The network helps show where Alexandra Berk may publish in the future.

Co-authorship network of co-authors of Alexandra Berk

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandra Berk. A scholar is included among the top collaborators of Alexandra Berk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandra Berk. Alexandra Berk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dai, Dingwei, et al.. (2024). Multimorbidity in Atherosclerotic Cardiovascular Disease and Its Associations With Adverse Cardiovascular Events and Healthcare Costs: A Real-World Evidence Study. Journal of health economics and outcomes research. 75–85. 4 indexed citations
2.
Fusco, Manuela Di, Xiaowu Sun, Kristen E. Allen, et al.. (2024). Effectiveness of BNT162b2 BA.4/5 Bivalent COVID-19 Vaccine against Long COVID Symptoms: A US Nationwide Study. Vaccines. 12(2). 183–183. 7 indexed citations
5.
Dai, Dingwei, Jonathan P. DeShazo, Xiaowu Sun, et al.. (2024). THE IMPACT OF LIPOPROTEIN(A) TESTING IN PATIENTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN A LARGE HEALTHCARE SYSTEM IN THE US. Journal of the American College of Cardiology. 83(13). 1690–1690. 2 indexed citations
6.
Dai, Dingwei, et al.. (2024). Multimorbidity in Atherosclerotic Cardiovascular Disease and Its Associations With Adverse Cardiovascular Events and Healthcare Costs: A Real-World Evidence Study. Journal of health economics and outcomes research. 11(1). 75–85. 2 indexed citations
7.
Lillard, James W., Alexandra Berk, James Gillespie, et al.. (2023). Increasing Clinical Trial Participation of Black Women Diagnosed with Breast Cancer. Journal of Racial and Ethnic Health Disparities. 11(3). 1701–1717. 2 indexed citations
8.
Liu, Xianchen, et al.. (2023). Financial Toxicity among Patients with Breast Cancer during the COVID-19 Pandemic in the United States. Cancers. 16(1). 62–62. 5 indexed citations
9.
Liu, Xianchen, Alexandra Berk, Marisa C. Weiss, et al.. (2023). Psychosocial Wellbeing among Patients with Breast Cancer during COVID-19. Current Oncology. 30(4). 3886–3900. 6 indexed citations
10.
Berk, Alexandra, et al.. (2023). Real-world Application of Racial and Ethnic Imputation and Cohort Balancing Techniques to Deliver Equitable Clinical Trial Recruitment.. PubMed. 2023. 319–328. 2 indexed citations
11.
Berk, Alexandra, Lynda Chin, Stacie Hudgens, et al.. (2023). A Study Design to Harmonize Patient-Reported Outcomes Across Data Sets. JCO Clinical Cancer Informatics. 7(7). e2200161–e2200161. 3 indexed citations
12.
Bachini, Melinda, et al.. (2022). Patient perspective: Financial toxicity is a barrier to clinical trials and personalized therapy in cholangiocarcinoma. Journal of Surgical Oncology. 126(6). 1011–1011.
13.
Bachini, Melinda, et al.. (2022). Patient reported outcomes: Financial toxicity is a barrier to clinical trials and personalized therapy in cholangiocarcinoma. Journal of Surgical Oncology. 126(6). 1003–1010. 3 indexed citations
15.
Cambron‐Mellott, M. Janelle, et al.. (2019). PND107 NEUROLOGIST AND PATIENT PREFERENCES IN MULTIPLE SCLEROSIS: UK AND US QUALITATIVE RESEARCH FINDINGS. Value in Health. 22. S757–S757. 3 indexed citations
16.
Atkinson, Thomas M., et al.. (2012). Development and Preliminary Evaluation of a Training Workshop for the Collection of Patient-Reported Outcome (PRO) Interview Data by Research Support Staff. Journal of Cancer Education. 28(1). 33–37. 1 indexed citations
17.
Burkhalter, Jack E., Seán Cahill, Elyse Shuk, et al.. (2012). At the Intersection of HIV/AIDS and Cancer. Health Education & Behavior. 40(4). 493–503. 9 indexed citations
18.
Schwartz, Lawrence H., David M. Panicek, Alexandra Berk, Yuelin Li, & Hedvig Hricak. (2011). Improving Communication of Diagnostic Radiology Findings through Structured Reporting. Radiology. 260(1). 174–181. 324 indexed citations
19.
Nelson, Christian J., Christina Cho, Alexandra Berk, Jimmie C. Holland, & Andrew Roth. (2009). Are Gold Standard Depression Measures Appropriate for Use in Geriatric Cancer Patients? A Systematic Evaluation of Self-Report Depression Instruments Used With Geriatric, Cancer, and Geriatric Cancer Samples. Journal of Clinical Oncology. 28(2). 348–356. 93 indexed citations
20.
Chang, Doris F. & Alexandra Berk. (2009). Making cross-racial therapy work: A phenomenological study of clients’ experiences of cross-racial therapy.. Journal of Counseling Psychology. 56(4). 521–536. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026